机构：[1]Department of Breast Cancer,Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China[2]Hospital Affiliated to Academy Military Medical Science, Beijing, China[3]Retired IBM Research, Saint Augustine, FL[4]The Affiliated Hospital of Qingdao University Medical College, Qingdao, China[5]Henan Tumor Hospital, Zhengzhou Henan, China河南省肿瘤医院[6]Jiangsu Province Hospital, Nanjing, China江苏省人民医院[7]Henan Cancer Hospital, Zhengzhou City, China河南省肿瘤医院[8]Qingdao Baheal Intelligent Technology Co., LTD, Qingdao, China[9]RXECONOMICS LLC, Hunt Valley, MD[10]The 4th Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院外一科临床科室[11]Jiangsu Cancer Hospital, Nanjing, China
第一作者机构：[1]Department of Breast Cancer,Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
推荐引用方式(GB/T 7714)：
Jiang Zefei,Xu Fengrui,Sepulveda Martin-J.,et al.Concordance, decision impact and guidelines adherence using artificial intelligence in high-risk breast cancer[J].JOURNAL OF CLINICAL ONCOLOGY.2018,36(15):doi:10.1200/JCO.2018.36.15_suppl.e18566.
APA：
Jiang, Zefei,Xu, Fengrui,Sepulveda, Martin-J.,Li, Jianbin,Wang, Haibo...&Tang, Jinhai.(2018).Concordance, decision impact and guidelines adherence using artificial intelligence in high-risk breast cancer.JOURNAL OF CLINICAL ONCOLOGY,36,(15)
MLA：
Jiang, Zefei,et al."Concordance, decision impact and guidelines adherence using artificial intelligence in high-risk breast cancer".JOURNAL OF CLINICAL ONCOLOGY 36..15(2018)
医学